A COMPARISON OF THE ANTI-RHINOVIRAL DRUG-BINDING POCKET IN HRV14 AND HRV1A

被引:81
作者
KIM, KH
WILLINGMANN, P
GONG, ZX
KREMER, MJ
CHAPMAN, MS
MINOR, I
OLIVEIRA, MA
ROSSMANN, MG
ANDRIES, K
DIANA, GD
DUTKO, FJ
MCKINLAY, MA
PEVEAR, DC
机构
[1] PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907
[2] UNIV WARWICK,DEPT BIOL SCI,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND
[3] JANSSEN RES FDN,B-2340 BEERSE,BELGIUM
[4] STERLING WINTHROP RES INST,DIV PHARMACEUT RES,RENSSELAER,NY 12144
关键词
ANTIVIRAL; DRUGS; RHINOVIRUS; HRV14; HRV1A;
D O I
10.1006/jmbi.1993.1137
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three-dimensional structures of twohuman rhinovirus serotypes (HRV14 and HRV1A) arecompared when complexed with various antiviral agents. Although these agents all hind into the same hydrophobic pocket, the exact viral-drug interactions differ. In the absence of drugs, the pocket is occupied by a fatty acid in HRV1A, but is empty in HRV14 except for two water molecules. The conformation of each drug is dependent upon the shape of the hydrophobic pocket. In HRV14 the major residues determining the shape of the binding site are Y1128, P1174 and M1224, corresponding to I1125, M1169 and I1220 in HRV1A. When there is no cofactor or a drug in the pocket, the entrance to the pocket is open. However, the entrance is closed when the pocket is occupied bya cofactor or a drug. There are relatively smallconformational changes when the agents displace the natural cofactor in HRV1A. In contrast, there are much larger conformational changes on binding a drag in HRV14. These differences cause an inhibition of viral attachment in HRV14 but not in HRV1A. Binding of the drugs results in three additional interprotomer hydrogen bonds in HRV14and one in HRV1A. These hydrogen bonds and a potential loss of flexibility upon efficient packing of the pocket may contribute to the inhibition of uncoating in both serotypes. © 1993 Academic Press, Inc.
引用
收藏
页码:206 / 226
页数:21
相关论文
共 51 条
[1]   MANY RHINOVIRUS SEROTYPES SHARE THE SAME CELLULAR RECEPTOR [J].
ABRAHAM, G ;
COLONNO, RJ .
JOURNAL OF VIROLOGY, 1984, 51 (02) :340-345
[2]   SUPPRESSION OF COLDS IN HUMAN VOLUNTEERS CHALLENGED WITH RHINOVIRUS BY A NEW SYNTHETIC DRUG (R61837) [J].
ALNAKIB, W ;
HIGGINS, PG ;
BARROW, GI ;
TYRRELL, DAJ ;
ANDRIES, K ;
VANDENBUSSCHE, G ;
TAYLOR, N ;
JANSSEN, PAJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) :522-525
[3]   INVITRO ACTIVITY OF PIRODAVIR (R-77975), A SUBSTITUTED PHENOXY-PYRIDAZINAMINE WITH BROAD-SPECTRUM ANTIPICORNAVIRAL ACTIVITY [J].
ANDRIES, K ;
DEWINDT, B ;
SNOEKS, J ;
WILLEBRORDS, R ;
VANEEMEREN, K ;
STOKBROEKX, R ;
JANSSEN, PAJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :100-107
[4]   INVITRO ACTIVITY OF R-61837, A NEW ANTIRHINOVIRUS COMPOUND [J].
ANDRIES, K ;
DEWINDT, B ;
DEBRABANDER, M ;
STOKBROEKX, R ;
JANSSEN, PAJ .
ARCHIVES OF VIROLOGY, 1988, 101 (3-4) :155-167
[5]   2 GROUPS OF RHINOVIRUSES REVEALED BY A PANEL OF ANTIVIRAL COMPOUNDS PRESENT SEQUENCE DIVERGENCE AND DIFFERENTIAL PATHOGENICITY [J].
ANDRIES, K ;
DEWINDT, B ;
SNOEKS, J ;
WOUTERS, L ;
MOEREELS, H ;
LEWI, PJ ;
JANSSEN, PAJ .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1117-1123
[6]   THERMAL-STABILITY AND PROTEIN-STRUCTURE [J].
ARGOS, P ;
ROSSMANN, MG ;
GRAU, UM ;
ZUBER, H ;
FRANK, G ;
TRATSCHIN, JD .
BIOCHEMISTRY, 1979, 18 (25) :5698-5703
[7]   ANALYSIS OF THE STRUCTURE OF A COMMON COLD VIRUS, HUMAN RHINOVIRUS-14, REFINED AT A RESOLUTION OF 3.0-A [J].
ARNOLD, E ;
ROSSMANN, MG .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 211 (04) :763-801
[8]   STRUCTURAL-ANALYSIS OF A SERIES OF ANTIVIRAL AGENTS COMPLEXED WITH HUMAN RHINOVIRUS-14 [J].
BADGER, J ;
MINOR, I ;
KREMER, MJ ;
OLIVEIRA, MA ;
SMITH, TJ ;
GRIFFITH, JP ;
GUERIN, DMA ;
KRISHNASWAMY, S ;
LUO, M ;
ROSSMANN, MG ;
MCKINLAY, MA ;
DIANA, GD ;
DUTKO, FJ ;
FANCHER, M ;
RUECKERT, RR ;
HEINZ, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3304-3308
[9]   STRUCTURAL-ANALYSIS OF ANTIVIRAL AGENTS THAT INTERACT WITH THE CAPSID OF HUMAN RHINOVIRUSES [J].
BADGER, J ;
MINOR, I ;
OLIVEIRA, MA ;
SMITH, TJ ;
ROSSMANN, MG .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (01) :1-19
[10]   HUMAN RHINOVIRUS-14 COMPLEXED WITH ANTIVIRAL COMPOUND R-61837 [J].
CHAPMAN, MS ;
MINOR, I ;
ROSSMANN, MG ;
DIANA, GD ;
ANDRIES, K .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 217 (03) :455-463